AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29482225 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 248
Study 26791430 — intervention group
Group type: EXPERIMENTAL
Intervention: New format of summary of findings (SoF) tables
Number of subjects: 290
Study 26791430 — intervention group
Group type: COMPARATOR
Intervention: Current format of summary of findings (SoF) tables
Number of subjects: 290
Study 24627207 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg intraventricular tissue plasminogen activator (TPA) every 12 h (maximum 10 mg)
Number of subjects: 12
Study 24627207 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 22526147 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training (individualized, high-intensity aerobic interval training)
Number of subjects: 24
Study 20022598 — intervention group
Group type: EXPERIMENTAL
Intervention: Top-hat LEEP
Number of subjects: 180
Study 20022598 — intervention group
Group type: COMPARATOR
Intervention: Conventional LEEP
Number of subjects: 180
Study 18591524 — intervention group
Group type: EXPERIMENTAL
Intervention: Vapocoolant spray
Number of subjects: 80
Study 18591524 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 16630999 — intervention group
Group type: EXPERIMENTAL
Intervention: lixivaptan 10, 30, 75, 150, 250, or 400 mg
Number of subjects: 42
Study 16630999 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 42
Study 16630999 — intervention group
Group type: EXPERIMENTAL
Intervention: lixivaptan (higher doses)
Number of subjects: 42
Study 11972383 — intervention group
Group type: EXPERIMENTAL
Intervention: Media recruitment strategy
Number of subjects: 2583
Study 11972383 — intervention group
Group type: COMPARATOR
Intervention: Clinic registry recruitment
Number of subjects: 2583
Study 10577530 — intervention group
Group type: EXPERIMENTAL
Intervention: Photocoagulation and aspirin treatment
Number of subjects: 2701
Study 10577530 — intervention group
Group type: COMPARATOR
Intervention: Not applicable (control group not specified)
Number of subjects: 2701
Study 8561333 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous spinal anesthesia (CSA) with 5 mg of 0.5% hyperbaric bupivacaine, followed by optional reinjection of 2.5 mg every 5 min
Number of subjects: 60
Study 8561333 — intervention group
Group type: COMPARATOR
Intervention: Single-dose spinal anesthesia (SDSA) with 10-15 mg of 0.5% hyperbaric bupivacaine
Number of subjects: 60
Study 8561333 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous spinal anesthesia (CSA)
Number of subjects: 60
Study 8561333 — intervention group
Group type: COMPARATOR
Intervention: Single-dose spinal anesthesia (SDSA)
Number of subjects: 60
Study 2008876 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-6 140-mL cups filtered decaffeinated coffee per day and 75 mg caffeine pills
Number of subjects: 69
Study 2008876 — intervention group
Group type: COMPARATOR
Intervention: 4-6 140-mL cups filtered decaffeinated coffee per day and placebo pills
Number of subjects: 69
Study 6351333 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine (0.6 mg)
Number of subjects: 60
Study 6351333 — intervention group
Group type: COMPARATOR
Intervention: Intravenous diazepam (10 mg) after intramuscular atropine (0.6 mg)
Number of subjects: 60
Study 6351333 — intervention group
Group type: COMPARATOR
Intervention: Saline (control) after intramuscular atropine (0.6 mg)
Number of subjects: 60
Study 29401529 — intervention group
Group type: EXPERIMENTAL
Intervention: Tissue flossing (3 treatments lasting 2 minutes each)
Number of subjects: 42
Study 29401529 — intervention group
Group type: EXPERIMENTAL
Intervention: Tissue flossing
Number of subjects: 42
Study 29401529 — intervention group
Group type: COMPARATOR
Intervention: Control group (no tissue flossing)
Number of subjects: 42
Study 29231589 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxibustion at Shenshu (BL 23) for 15 min, once a day, for 4 courses with 2 days interval between courses
Number of subjects: 60
Study 29231589 — intervention group
Group type: COMPARATOR
Intervention: Oral administration of soft capsule of Vitamin E, once a day for 28 days
Number of subjects: 60
Study 25660952 — intervention group
Group type: EXPERIMENTAL
Intervention: AHA-R (American Heart Association recommendation)
Number of subjects: 220
Study 25660952 — intervention group
Group type: EXPERIMENTAL
Intervention: ERC-R (European Resuscitation Council recommendation)
Number of subjects: 220
Study 25660952 — intervention group
Group type: EXPERIMENTAL
Intervention: AHA-R
Number of subjects: 220
Study 25660952 — intervention group
Group type: EXPERIMENTAL
Intervention: ERC-R
Number of subjects: 220
Study 23325537 — intervention group
Group type: EXPERIMENTAL
Intervention: Thought-shape fusion (TSF) induction
Number of subjects: 82
Study 23325537 — intervention group
Group type: COMPARATOR
Intervention: Neutral induction
Number of subjects: 82
Study 23325537 — intervention group
Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 82
Study 20921239 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet intervention
Number of subjects: 54
Study 20921239 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 54
Study 18719752 — intervention group
Group type: EXPERIMENTAL
Intervention: Trained group (physical exercise program including aerobic training, muscle strength training, agility and joint flexibility activities)
Number of subjects: 42
Study 18719752 — intervention group
Group type: COMPARATOR
Intervention: Untrained group (no exercise program)
Number of subjects: 42
Study 17015814 — intervention group
Group type: EXPERIMENTAL
Intervention: Scopolamine hydrobromide (4 microg/kg)
Number of subjects: 18
Study 17015814 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 14617718 — intervention group
Group type: EXPERIMENTAL
Intervention: acetylcholinesterase inhibitor (donepezil)
Number of subjects: 12
Study 14617718 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study 11933449 — intervention group
Group type: EXPERIMENTAL
Intervention: Visco-elastic foam mattress
Number of subjects: 101
Study 11933449 — intervention group
Group type: COMPARATOR
Intervention: Standard mattress
Number of subjects: 101
Study 9039344 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone (up to 0.25 U/kg/week in daily doses)
Number of subjects: 20
Study 9039344 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 8249050 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine skin patches (three different doses applied to different groups)
Number of subjects: 24
Study 8249050 — intervention group
Group type: EXPERIMENTAL
Intervention: Saliva collection methods (sucking on a lemon candy, dissolving a sugar cube in the mouth, chewing on parafilm)
Number of subjects: 24
Study 2861526 — intervention group
Group type: EXPERIMENTAL
Intervention: Spectacles with left lens occluded
Number of subjects: 148
Study 2861526 — intervention group
Group type: COMPARATOR
Intervention: Plain spectacles (untreated)
Number of subjects: 148
Study 31399431 — intervention group
Group type: EXPERIMENTAL
Intervention: Type 2 diabetes genetic risk score (comprising 48 established risk variants)
Number of subjects: 160000
Study 28857223 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceptual support for accurately encoding the equal sign
Number of subjects: 0
Study 28857223 — intervention group
Group type: COMPARATOR
Intervention: Control condition (feedback only)
Number of subjects: 0
Study 26757793 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flavonoid (HF) intake with increased F&V by 2, 4, and 6 portions for 6 weeks
Number of subjects: 122
Study 26757793 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-flavonoid (LF) intake with increased F&V by 2, 4, and 6 portions for 6 weeks
Number of subjects: 122
Study 26757793 — intervention group
Group type: COMPARATOR
Intervention: Control group with habitual diet
Number of subjects: 122
Study 25864712 — intervention group
Group type: EXPERIMENTAL
Intervention: Challenge-proven cow's milk allergy (CMA)
Number of subjects: 12049
Study 25864712 — intervention group
Group type: EXPERIMENTAL
Intervention: Re-evaluation of children with CMA after one year
Number of subjects: 12049
Study 23012270 — intervention group
Group type: EXPERIMENTAL
Intervention: Duchenne smile
Number of subjects: 170
Study 23012270 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard smile
Number of subjects: 170
Study 23012270 — intervention group
Group type: COMPARATOR
Intervention: Neutral expression
Number of subjects: 170
Study 23012270 — intervention group
Group type: EXPERIMENTAL
Intervention: Duchenne smile (not explicitly asked to smile)
Number of subjects: 170
Study 23012270 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard smile (not explicitly asked to smile)
Number of subjects: 170
Study 20436440 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebrolysin
Number of subjects: 110
Study 20436440 — intervention group
Group type: COMPARATOR
Intervention: Cavinton
Number of subjects: 110
Study 18543837 — intervention group
Group type: EXPERIMENTAL
Intervention: Breastfeeding educational program (5 sessions during hospitalization and after discharge)
Number of subjects: 60
Study 18543837 — intervention group
Group type: EXPERIMENTAL
Intervention: Breastfeeding educational program
Number of subjects: 60
Study 18543837 — intervention group
Group type: COMPARATOR
Intervention: Control group (no educational program)
Number of subjects: 60
Study 15759073 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients' beliefs about pain management
Number of subjects: 342
Study 15759073 — intervention group
Group type: EXPERIMENTAL
Intervention: Providers' pain management practices
Number of subjects: 342
Study 15759073 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with recent moderate to severe pain
Number of subjects: 342
Study 12490345 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 0
Study 10406622 — intervention group
Group type: EXPERIMENTAL
Intervention: Ab-interno goniotrabeculotomy (AIGT)
Number of subjects: 32
Study 10406622 — intervention group
Group type: COMPARATOR
Intervention: Mitomycin C trabeculectomy (MT)
Number of subjects: 32
Study 7734261 — intervention group
Group type: EXPERIMENTAL
Intervention: Forced warm air convective heating blanket
Number of subjects: 0
Study 7734261 — intervention group
Group type: COMPARATOR
Intervention: Electric under mattress
Number of subjects: 0
Study 7734261 — intervention group
Group type: COMPARATOR
Intervention: Warm air under mattress
Number of subjects: 0
Study 1916494 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole 20 mg/kg
Number of subjects: 105
Study 1916494 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole 10 mg/kg
Number of subjects: 105
Study 1916494 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study 1916494 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole (combined 20 mg/kg and 10 mg/kg)
Number of subjects: 105
Study 393035 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral retinoid (25 mg three times a day for six weeks)
Number of subjects: 0
Study 30514775 — intervention group
Group type: EXPERIMENTAL
Intervention: DC–CIK combined with S‐1 plus cisplatin
Number of subjects: 63
Study 30514775 — intervention group
Group type: EXPERIMENTAL
Intervention: DC–CIK combined with S‐1
Number of subjects: 63
Study 30514775 — intervention group
Group type: EXPERIMENTAL
Intervention: S‐1 plus cisplatin
Number of subjects: 63
Study 30514775 — intervention group
Group type: EXPERIMENTAL
Intervention: S‐1 alone
Number of subjects: 63
Study 30514775 — intervention group
Group type: EXPERIMENTAL
Intervention: DC–CIK infusions
Number of subjects: 63
Study 30514775 — intervention group
Group type: EXPERIMENTAL
Intervention: Decreased ctDNA mutational frequency and restored TCR repertoire
Number of subjects: 63
Study 26197987 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient admission protocol (experimental group)
Number of subjects: 100
Study 26197987 — intervention group
Group type: COMPARATOR
Intervention: Routine admittance (control group)
Number of subjects: 100
Study 25464161 — intervention group
Group type: EXPERIMENTAL
Intervention: Administrator survey evaluating organizational safety structures and processes
Number of subjects: 507
Study 25464161 — intervention group
Group type: EXPERIMENTAL
Intervention: Staff survey querying safety and communication concerns
Number of subjects: 507
Study 25464161 — intervention group
Group type: EXPERIMENTAL
Intervention: Referral and test result management systems
Number of subjects: 507
Study 25464161 — intervention group
Group type: EXPERIMENTAL
Intervention: MD/PA/NPs perceptions of high-risk system reliability
Number of subjects: 507
Study 25464161 — intervention group
Group type: EXPERIMENTAL
Intervention: MD/PA/NPs perceptions of teamwork
Number of subjects: 507
Study 22855271 — intervention group
Group type: COMPARATOR
Intervention: Vardenafil (0.3-3 mg/kg) in rats; administered orally 30 min before testing.
Number of subjects: 0
Study 22855271 — intervention group
Group type: COMPARATOR
Intervention: Vardenafil (10-20 mg) in humans; administered 85 min before testing.
Number of subjects: 0
Study 22855271 — intervention group
Group type: COMPARATOR
Intervention: Placebo in humans; administered 85 min before testing.
Number of subjects: 0
Study 16909130 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity physical activity intervention
Number of subjects: 173
Study 16909130 — intervention group
Group type: COMPARATOR
Intervention: Stretching control group
Number of subjects: 173
Study 15609487 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulation intervention
Number of subjects: 131
Study 15609487 — intervention group
Group type: COMPARATOR
Intervention: Stabilization intervention
Number of subjects: 131
Study 10871150 — intervention group
Group type: EXPERIMENTAL
Intervention: CSP/MTX/PSE
Number of subjects: 186
Study 10871150 — intervention group
Group type: COMPARATOR
Intervention: CSP/MTX
Number of subjects: 186
Study 9093656 — intervention group
Group type: EXPERIMENTAL
Intervention: Questionnaire assessment of occupational activities
Number of subjects: 152
Study 8210543 — intervention group
Group type: EXPERIMENTAL
Intervention: Thymopentin 50 mg s.c. every other day, after irradiation for at least 6 cycles of 4 weeks each
Number of subjects: 1060
Study 8210543 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1060
Study 3740202 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhibitive ankle-foot orthoses
Number of subjects: 1
Study 29947729 — intervention group
Group type: EXPERIMENTAL
Intervention: High-emotion pictorial warnings
Number of subjects: 0
Study 29947729 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-emotion pictorial warnings
Number of subjects: 0
Study 29947729 — intervention group
Group type: COMPARATOR
Intervention: Text-only warnings
Number of subjects: 0
Study 28293470 — intervention group
Group type: EXPERIMENTAL
Intervention: ABT‐436 800 mg QD
Number of subjects: 51
Study 28293470 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study 26430826 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic supplementation (2 capsules/day for 8 weeks)
Number of subjects: 42
Study 26430826 — intervention group
Group type: COMPARATOR
Intervention: Placebo (2 capsules/day for 8 weeks)
Number of subjects: 42
Study 24215730 — intervention group
Group type: EXPERIMENTAL
Intervention: PocketCPR
Number of subjects: 240
Study 24215730 — intervention group
Group type: EXPERIMENTAL
Intervention: CPRmeter
Number of subjects: 240
Study 24215730 — intervention group
Group type: EXPERIMENTAL
Intervention: iPhone app PocketCPR
Number of subjects: 240
Study 24215730 — intervention group
Group type: COMPARATOR
Intervention: Standard BLS
Number of subjects: 240
Study 21830124 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapeutics plus verapamil infusion
Number of subjects: 100
Study 21830124 — intervention group
Group type: COMPARATOR
Intervention: Targeted intra-arterial infusion (control)
Number of subjects: 100
Study 21830124 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil infusion
Number of subjects: 100
Study 19219314 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial shockwave treatment (three applications, once a week)
Number of subjects: 32
Study 19219314 — intervention group
Group type: COMPARATOR
Intervention: Conventional physiotherapy (10 sessions of ultrasound, kinesiotherapy, and stretching instruction)
Number of subjects: 32
Study 17309575 — intervention group
Group type: EXPERIMENTAL
Intervention: Midodrine hydrochloride (MID) at 4 mg/day
Number of subjects: 13
Study 17309575 — intervention group
Group type: EXPERIMENTAL
Intervention: L-threo-3,4-dihydroxyphenylserine (L-DOPS) at 400 mg/day
Number of subjects: 13
Study 17309575 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 13
Study 15112344 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGH+PN group
Number of subjects: 24
Study 15112344 — intervention group
Group type: COMPARATOR
Intervention: PN group
Number of subjects: 24
Study 12378829 — intervention group
Group type: EXPERIMENTAL
Intervention: PTH 1-34
Number of subjects: 0
Study 12378829 — intervention group
Group type: EXPERIMENTAL
Intervention: Strontium salt (oral administration at low dosage)
Number of subjects: 0
Study 12378829 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose intermittent fluoride therapy
Number of subjects: 0
Study 12378829 — intervention group
Group type: EXPERIMENTAL
Intervention: Statins
Number of subjects: 0
Study 12378829 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin-like growth factor I and other growth factors
Number of subjects: 0
Study 9660327 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose ethanol (LD)
Number of subjects: 50
Study 9660327 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose ethanol (HD)
Number of subjects: 50
Study 9660327 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 50
Study 7665724 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitoxantrone (cumulative dose of 96 mg/m2)
Number of subjects: 20
Study 7665724 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 7665724 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitoxantrone
Number of subjects: 20
Study 2501110 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal (IN) Buserelin (300 micrograms three times a day)
Number of subjects: 100
Study 2501110 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous (SC) Buserelin implant (6.6 mg Buserelin)
Number of subjects: 100
Study 782796 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate aerosol (400 mug daily)
Number of subjects: 32
Study 782796 — intervention group
Group type: COMPARATOR
Intervention: Placebo aerosol
Number of subjects: 32
Study 782796 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate aerosol
Number of subjects: 32
Study 31633896 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 532
Study 31633896 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 532
Study 28218552 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm A (newly-defined common technique for palatal repair)
Number of subjects: 448
Study 28218552 — intervention group
Group type: COMPARATOR
Intervention: Arms C or D (traditional local protocols)
Number of subjects: 448
Study 26039125 — intervention group
Group type: EXPERIMENTAL
Intervention: Low intensity lifestyle modification (LILM) program for 6 months, including 4 interactive group discussion sessions and weekly phone contact with volunteer counselors.
Number of subjects: 0
Study 26039125 — intervention group
Group type: COMPARATOR
Intervention: Noninteractive session on diet and physical activity (comparison group).
Number of subjects: 0
Study 23344468 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose prednisolone (1 mg/Kg/dose 24 h before surgery)
Number of subjects: 80
Study 23344468 — intervention group
Group type: COMPARATOR
Intervention: 5-day prednisolone (1 mg/Kg/day before operation)
Number of subjects: 80
Study 23344468 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgeons' opinion about surgery field quality
Number of subjects: 80
Study 20715901 — intervention group
Group type: EXPERIMENTAL
Intervention: Sourdough prepared with LV4 starter (Lactobacillus brevis combined with Saccharomyces cerevisiae var. chevalieri)
Number of subjects: 0
Study 20715901 — intervention group
Group type: EXPERIMENTAL
Intervention: Sourdough prepared with PL1 starter (Lactobacillus fermentum)
Number of subjects: 0
Study 20715901 — intervention group
Group type: EXPERIMENTAL
Intervention: Sourdough prepared with PL3 starter (Lactobacillus fermentum with phytase)
Number of subjects: 0
Study 20715901 — intervention group
Group type: EXPERIMENTAL
Intervention: Sourdough prepared with L. plantarum
Number of subjects: 0
Study 20715901 — intervention group
Group type: COMPARATOR
Intervention: Control bread without sourdough
Number of subjects: 0
Study 19258723 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 70
Study 19258723 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide
Number of subjects: 70
Study 17081831 — intervention group
Group type: EXPERIMENTAL
Intervention: Universal-free school breakfast offered in treatment schools for three consecutive school years (2000-2001 to 2002-2003)
Number of subjects: 4358
Study 17081831 — intervention group
Group type: COMPARATOR
Intervention: Traditional means-tested School Breakfast Program in control schools
Number of subjects: 4358
Study 15466731 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrohydraulic high-energy shock waves treatment
Number of subjects: 364
Study 15466731 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 364
Study 11304780 — intervention group
Group type: EXPERIMENTAL
Intervention: Local excision alone
Number of subjects: 1010
Study 11304780 — intervention group
Group type: EXPERIMENTAL
Intervention: Poorly differentiated DCIS
Number of subjects: 1010
Study 11304780 — intervention group
Group type: EXPERIMENTAL
Intervention: Young age (<= 40 years)
Number of subjects: 1010
Study 11304780 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptomatic detection of DCIS
Number of subjects: 1010
Study 11304780 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth pattern (solid and cribriform)
Number of subjects: 1010
Study 11304780 — intervention group
Group type: EXPERIMENTAL
Intervention: Involved margins
Number of subjects: 1010
Study 11304780 — intervention group
Group type: COMPARATOR
Intervention: Histologic type of DCIS
Number of subjects: 1010
Study 9165360 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifurcated e PTFE graft with stretch properties
Number of subjects: 14